Assessment of efficacy and safety of imatinib as an adjunct host-targeted therapy for parasite clearance in chloroquine-resistant malaria: a prospective case control study

Abstract Overview Chloroquine-resistant malaria poses a significant treatment challenge, especially in endemic areas. Host-targeted therapies, like tyrosine kinase inhibitors (TKIs) such as imatinib, have shown potential to improve malaria treatment outcomes by disrupting parasite egress from red bl...

Full description

Saved in:
Bibliographic Details
Main Authors: Fazeel Zubair Ahmed, Shaifulla P
Format: Article
Language:English
Published: SpringerOpen 2025-01-01
Series:The Egyptian Journal of Internal Medicine
Subjects:
Online Access:https://doi.org/10.1186/s43162-025-00399-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items